Journal of Infection
Volume 61, Issue 2 , Pages 125-132 , August 2010

Six weeks of antibiotic treatment is sufficient following surgery for septic arthroplasty

  • Louis Bernard

      Affiliations

    • Orthopaedic Surgery Service, Geneva University Hospitals & Medical School, Geneva, Switzerland
    • Division of Infectious Diseases, Bretionneau Hospital, University Hospitals of Tours, France
    • ,
  • Laurence Legout

      Affiliations

    • Orthopaedic Surgery Service, Geneva University Hospitals & Medical School, Geneva, Switzerland
    • ,
  • Line Zürcher-Pfund

      Affiliations

    • Orthopaedic Surgery Service, Geneva University Hospitals & Medical School, Geneva, Switzerland
    • ,
  • Richard Stern

      Affiliations

    • Orthopaedic Surgery Service, Geneva University Hospitals & Medical School, Geneva, Switzerland
    • ,
  • Peter Rohner

      Affiliations

    • Laboratory of Bacteriology, Geneva University Hospitals & Medical School, Geneva, Switzerland
    • ,
  • Robin Peter

      Affiliations

    • Orthopaedic Surgery Service, Geneva University Hospitals & Medical School, Geneva, Switzerland
    • ,
  • Mathieu Assal

      Affiliations

    • Orthopaedic Surgery Service, Geneva University Hospitals & Medical School, Geneva, Switzerland
    • ,
  • Daniel Lew

      Affiliations

    • Service of Infectious Diseases, Geneva University Hospitals & Medical School, Geneva, Switzerland
    • ,
  • Pierre Hoffmeyer

      Affiliations

    • Orthopaedic Surgery Service, Geneva University Hospitals & Medical School, Geneva, Switzerland
    • ,
  • Ilker Uçkay

      Affiliations

    • Orthopaedic Surgery Service, Geneva University Hospitals & Medical School, Geneva, Switzerland
    • Service of Infectious Diseases, Geneva University Hospitals & Medical School, Geneva, Switzerland
    • Corresponding Author InformationCorresponding author. Orthopaedic Surgery Service, Service of Infectious Diseases, Geneva University Hospitals, 4, Rue Gabrielle Perret-Gentil, 1211 Geneva 14, Switzerland. Tel.: +41 22 372 3311; fax: +41 22 372 3987.

,Accepted 29 May 2010.

References 

  1. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Eng J Med. 2004;351:1645–1654
  2. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. JAMA. 1998;279:1537–1541
  3. Bengtson S. Prosthetic osteomyelitis with special reference to the knee: risks, treatment and costs. Ann Med. 1993;25:523–529
  4. Uçkay I, Pittet D, Vaudaux P, Sax H, Lew D, Waldvogel F. Foreign body infections due to Staphylococcus epidermidis. Ann Med. 2009;41:109–119
  5. Bernard L, Hoffmeyer P, Assal M, Vaudaux P, Schrenzel J, Lew D. Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother. 2004;53:127–129
  6. Trampuz A, Zimmerli W. Antimicrobial agents in orthopaedic surgery: Prophylaxis and treatment. Drugs. 2006;66:1089–1105
  7. Kösters K, van Crevel R, Sturm PD, Willem Schreurs B, de Waal Malefijt MC, van Kampen A, et al. Treatment of knee prosthesis infections: evaluation of 15 patients over a 5-year period. Int Orthop. 2008;33:1249–1254
  8. Laffer RR, Graber P, Ochsner PE, Zimmerli W. Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect. 2006;12:433–439
  9. Volin SJ, Hinrichs SH, Garvin KL. Two-stage reimplantation of total joint infections: a comparison of resistant and non-resistant organisms. Clin Orthop Relat Res. 2004;427:94–100
  10. Mermel LA, Farr BM, Sherertz RJ, Raad II, O’Grady N, Harris JS, et al. Guidelines for the management of intravascular catheter-related infections. Infect Control Hosp Epidemiol. 2001;22:222–242
  11. Pulcini C, Couadau T, Bernard E, Lorthat-Jacob A, Bauer T, Cua E, et al. Adverse effects of parenteral antimicrobial therapy for chronic bone infections. Eur J Clin Microbiol Infect Dis. 2008;27:1227–1232
  12. Uçkay I, Vernaz-Hegi N, Harbarth S, Stern R, Legout L, Vauthey L, et al. Activity and impact on antibiotic use and costs of a dedicated infectious diseases consultant on a septic orthopaedic unit. J Infect. 2009;58:205–212
  13. Lübbeke A, Stern R, Garavaglia G, Zürcher L, Hoffmeyer P. Differences in outcomes of obese women and men undergoing primary total hip arthroplasty. Arthritis Rheum. 2007;57:327–334
  14. Wayne P. Performance standards for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute; 2007;17th informational supplement (Standard M100-S17)
  15. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710–718
  16. Kilgus DJ, Howe DJ, Strang A. Results of periprosthetic hip and knee infections caused by resistant bacteria. Clin Orthop Relat Res. 2002;404:116–124
  17. Byren I, Bejon P, Atkins BL, Angus B, Masters S, McLardy-Smith P, et al. One hundred and twelve infected arthroplasties treated with ’DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother. 2009;63:1264–1271
  18. Betsch BY, Eggli S, Siebenrock KA, Täuber MG, Mühlemann K. Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clin Infect Dis. 2008;46:1221–1226
  19. Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Harmsen SW, Mandrekar JN, et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis. 2006;42:471–478
  20. Brandt CM, Sistrunk WW, Duffy MC, Hanssen AD, Steckelberg JM, Ilstrup DM, et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis. 1997;24:914–919
  21. Farhad R, Roger PM, Albert C, Pélligri C, Touati C, Dellamonica P, et al. Six weeks antibiotic therapy for all bone infections: results of a cohort study. Eur J Clin Microbiol Infect Dis. 2009;29:217–222
  22. Smilack JD, Flittie WH, Williams TW. Bone concentrations of antimicrobial agents after parenteral administration. Antimicrob Agents Chemother. 1976;9:169–171
  23. Daver NG, Shelburne SA, Atmar RL, Giordano TP, Stager CE, Reitman CA, et al. Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis. J Infect. 2007;54:539–544
  24. Darley ES, MacGowan AP. Antibiotic treatment of gram-positive bone and joint infections. J Antimicrob Chemother. 2004;53:928–935
  25. Toma MB, Smith KM, Martin CA, Rapp RP. Pharmacokinetic considerations in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis. Orthopedics. 2006;29:497–501
  26. Berendt AR, Peters EJ, Bakker K, Embil JM, Eneroth M, Hinchliffe RJ, et al. Specific guidelines for treatment of diabetic foot osteomyelitis. Diabetes Metab Res Rev. 2008;24:190–191
  27. Heldman AW, Hartert TV, Ray SC, Daoud EG, Kowalski TE, Pompili VJ, et al. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med. 1996;101:68–76
  28. Vaudaux P, Kelley WL, Lew DP. Staphylococcus aureus small colony variants: difficult to diagnose and difficult to treat. Clin Infect Dis. 2006;43:968–970

☆ There are no grants, financial support, financial interests, consultancy, commercial or other associations that could lead to a conflict of interest. All authors state that they have read and approved the manuscript. It has not been published elsewhere nor is it under consideration for publication by another journal. Different parts of the manuscript have been presented orally at the 6th and 10th French National Days of Infectiology, in Nice 2005 and Lyon 2009, respectively, and the Swiss Orthopaedic Congress in Geneva, June 2009.

PII: S0163-4453(10)00153-2

doi: 10.1016/j.jinf.2010.05.005

Journal of Infection
Volume 61, Issue 2 , Pages 125-132 , August 2010

Article Tools